GCC Oncology/Cancer Drugs Market Demand, Drivers and Opportunities 2023-2030
The GCC Oncology/Cancer Drugs Market report by MarkNtel Advisors – Market Research Company, offers a comprehensive analysis of the size, share & growth of the market.
The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), GCC Oncology/Cancer Drugs Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape. The research company provides an extensive range of strategic reports on diverse industry verticals to substantial and varied client bases, including multinational corporations, financial institutions, governments, and individuals, among others.
GCC Oncology/Cancer Drugs Industry Analytical Overview (2023-2030): Drivers, Opportunities, Challenges, and Trends,
According to the latest report, GCC Oncology/Cancer Drugs Market is projected to grow at a considerable CAGR during the forecast period, i.e., 2023-28. The report significantly addressed considerable changes, gap analyses, and competitive studies using qualitative and quantitative data. These include the widespread segmentation, geography, and recent developments, entailing information on the fluctuation in the demand, sales, revenue, and other parameters experienced and expected in the industry for the forecasting year i.e. 2023 to 2030.
Download Report Sample PDF - https://www.marknteladvisors.com/query/request-sample/gcc-oncology-cancer-drugs-market.html
What is Included in GCC Oncology/Cancer Drugs Market Segmentation?
The report has segmented the market into the following categories:
By Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Hormonal Therapy
- Others
By Application
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Liver cancer
- Ovarian Cancer
- Prostate Cancer
- Skin Cancer
- Pancreatic Cancer
- Colorectal
- Blood Cancer
- Others
Breast cancer is among the leading reasons for the death of women in the region. In UAE, 1,054 new cases of breast cancer were registered in 2018. Women around the age of 40 and above are likely to develop breast cancer. To reduce the overall mortality rate, various steps are being taken by the governments for the production of oncology drugs for breast cancer. Besides this, numerous Breast Cancer Awareness and Prevention programs are also initiated by the governments in the region to spread awareness amongst women about the disease and to enable them toward early detection and diagnosis, prevention, and treatment methods. Thus, these factors are expected to catalyze the market growth of Oncology/Cancer Drugs in the forecast period.
By Country
- Saudi Arabia
- The UAE
- Qatar
- Kuwait
- Bahrain
- Oman
("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")
Access the Complete Report for An In-Depth Analysis - https://www.marknteladvisors.com/research-library/gcc-oncology-cancer-drugs-market.html
Key Factor Driver GCC Oncology/Cancer Drugs Industry Growth by 2030
The GCC nations have been witnessing a massive surge in several types of cancer cases including lung cancer, breast cancer, colorectal cancer, prostate cancer, etc. The prominent factor behind the increasing cases of lung cancer in the GCC nations remains the habit of tobacco smoking among the men population. The smoking prevalence has been subsequently leading to a large number of lung cancer cases mainly in Saudi Arabia, Bahrain, and Oman. For instance, in 2020, around 6% male of Saudi Arabia were diagnosed with lung cancer, as per the World Health Organization. Thus, the growing prevalence of different types of cancers among the GCC population would facilitate the requirement for oncology/cancer drugs in the forthcoming period.
Who are the Key Players Operating in the GCC Oncology/Cancer Drugs Industry?
The top companies of the GCC Oncology/Cancer Drugs market ruling the industry are:
- Hoffmann-La Roche Ltd.
- Johnson & Johnson Middle East FZ LLC
- Pfizer International Corporation
- Merck Serono Middle East FZ-Ltd.
- AbbVie Biopharmaceuticals GmbH
- AstraZeneca Gulf FZ LLC
- Bayer Middle East FZE
- Amgen, Inc.
- Astellas MENA/SSA
- Others
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
Click Here to Connect with Our Expertise - https://www.marknteladvisors.com/query/talk-to-our-consultant/gcc-oncology-cancer-drugs-market.html
Key Objectives of Choosing Markntel Advisor’s Report
- Focused Industry Expertise
- Diverse Report Offerings
- Personalized Research Solutions
- Robust Research Methodology
- In-depth Report Coverage
- Tracking Technological Advancements
- Comprehensive Value-Chain Analysis
- Discovering Market Opportunities
- Analysing Growth Trajectories
- Assured Quality Insights
- Dedicated After-Sales Support
FAQs (Frequently Ask Questions)
- What are the industry’s overall statistics or estimates including CARG and USD Value of the forecasting years?
- What are the trends influencing the current scenario of the GCC Oncology/Cancer Drugs Market?
- What are the key factors that would propel and hinder the industry?
- Which geographical area dominates the GCC Oncology/Cancer Drugs industry?
- Which is the Leading segment in the market?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Media Inquiries, Please Contact:
Phone: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
What's Your Reaction?
